Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

House investigators nix Mueller testimony in Epstein probe over health concerns

by admin August 30, 2025
August 30, 2025
House investigators nix Mueller testimony in Epstein probe over health concerns

House investigators’ plan to grill former FBI Director Robert Mueller has hit a snag. 

The House Oversight Committee was set to have Mueller appear before the panel on Tuesday as part of the House’s probe into Jeffrey Epstein. However, a source familiar with the investigation told Fox News Digital that lawmakers ‘learned that Mr. Mueller has health issues that preclude him from being able to testify.’ 

‘The committee intends to withdraw its subpoena,’ the source said. 

Mueller was one of many notable figures, including the Clintons, who House Oversight Committee Chair James Comer, R-Ky., subpoenaed to testify before the panel. 

He would have been the second witness appearing in-person before the House Oversight Committee after former Attorney General Bill Barr did so last month.

His closed-door deposition was expected to see at least some lawmakers on both sides attend, with the investigation so far seeing wide bipartisan support in an otherwise highly divided era for Congress.

Mueller was most recently in the headlines for his role as special counsel investigating whether Russia interfered in the 2016 election in favor of President Donald Trump.

That probe, which did not find Trump to have committed any wrongdoing, saw 34 people indicted and eight convictions or guilty pleas, including several people associated with the president.

House investigators were expected to dive into Mueller’s time as director of the FBI. He led the bureau under former Presidents George W. Bush and Barack Obama, from September 2001 until September 2013.

It was during that window that the federal government first investigated Epstein, something Comer pointed out in his letter subpoenaing Mueller.

‘When you were FBI Director, an FBI investigation of Mr. Epstein led to an Assistant U.S. Attorney in the Southern District of Florida preparing a draft 60-count indictment of Mr. Epstein in 2007,’ Comer wrote.

‘However, the next year, Mr. Epstein pled guilty in Florida state court to two prostitution offenses, and, in exchange, he and his co-conspirators received immunity from federal prosecution through a non-prosecution agreement.’

That non-prosecution agreement has been widely criticized and is now the basis for Epstein accomplice Ghislaine Maxwell to appeal her conviction and 20-year prison sentence before the Supreme Court.

It’s not clear how much of a role Mueller would have had in that agreement. Alexander Acosta, the former Trump labor secretary and U.S. attorney in Florida who signed off on the deal, is sitting down with the House Oversight Committee for a voluntary transcribed interview later this month.

Comer sent out a flurry of subpoenas last month in relation to the Epstein probe. 

Other figures also compelled to appear after Mueller are former FBI Director James Comey, former Attorney General Loretta Lynch and ex-first couple Bill and Hillary Clinton.

This post appeared first on FOX NEWS

previous post
Charbone Hydrogene annonce les resultats financiers T2 2025
next post
Is Putin stringing Trump along to sidestep US sanctions while bombing Ukraine?

Related Posts

Sen Cotton warns Iran to seek peace, lists...

June 23, 2025

Here’s what Trump is really up to with...

April 6, 2025

Inside Biden confidante Steve Ricchetti’s ‘combative’ eight-hour grilling...

July 31, 2025

Grassley rebukes Trump’s pressure to ‘have the courage’...

July 31, 2025

Trump criticizes Schumer, says Dem leader ‘has become...

March 13, 2025

Trump promises to ramp up energy production, lower...

March 5, 2025

Pakistan says it has struck military targets inside...

May 10, 2025

Republicans troll Dems’ El Salvador visits with offer...

April 23, 2025

Secretary of State Rubio hails release of US...

January 27, 2025

South Korea presidential ouster part of Chinese strategy...

April 6, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 5

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved